These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26724543)

  • 21. Enhanced immune responses in pigs by DNA vaccine coexpressing GP3 and GP5 of European type porcine reproductive and respiratory syndrome virus.
    Ren J; Lu H; Wen S; Sun W; Yan F; Chen X; Jing J; Liu H; Liu C; Xue F; Xiao P; Xin S; Jin N
    J Virol Methods; 2014 Sep; 206():27-37. PubMed ID: 24882496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
    Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
    Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.
    Dwivedi V; Manickam C; Patterson R; Dodson K; Murtaugh M; Torrelles JB; Schlesinger LS; Renukaradhya GJ
    Vaccine; 2011 May; 29(23):4058-66. PubMed ID: 21419162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Two Commercial Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Modified Live Vaccines against Heterologous Type 1 and Type 2 PRRSV Challenge in Growing Pigs.
    Kim T; Park C; Choi K; Jeong J; Kang I; Park SJ; Chae C
    Clin Vaccine Immunol; 2015 Jun; 22(6):631-40. PubMed ID: 25855554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
    Kristensen CS; Kvisgaard LK; Pawlowski M; Holmgaard Carlsen S; Hjulsager CK; Heegaard PMH; Bøtner A; Stadejek T; Haugegaard S; Larsen LE
    Vaccine; 2018 Jan; 36(2):227-236. PubMed ID: 29191738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of commercial modified-live PRRSV-1 and PRRSV-2 vaccines against a dual heterologous PRRSV-1 and PRRSV-2 challenge in late term pregnancy gilts.
    Yang S; Oh T; Cho H; Chae C
    Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101423. PubMed ID: 31972500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant Porcine Interferon Alpha Enhances Immune Responses to Killed Porcine Reproductive and Respiratory Syndrome Virus Vaccine in Pigs.
    Yu HY; Qu MS; Zhang JL; Gan L; Zhao Y; Shan XQ; Zhou W; Xia BB; Chen J; Wang ML; Zhao J
    Viral Immunol; 2019 Nov; 32(9):383-392. PubMed ID: 31693458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-protection of a new type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccine (Fostera PRRS) against heterologous type 1 PRRSV challenge in growing pigs.
    Park C; Choi K; Jeong J; Chae C
    Vet Microbiol; 2015 May; 177(1-2):87-94. PubMed ID: 25769646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive inductive effect of IL-2 on virus-specific cellular responses elicited by a PRRSV-ORF7 DNA vaccine in swine.
    Rompato G; Ling E; Chen Z; Van Kruiningen H; Garmendia AE
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):151-60. PubMed ID: 16162362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Porcine GPX1 enhances GP5-based DNA vaccination against porcine reproductive and respiratory syndrome virus.
    Du L; Li B; Pang F; Yu Z; Xu X; Fan B; Tan Y; He K; Huang K
    Vet Immunol Immunopathol; 2017 Jan; 183():31-39. PubMed ID: 28063474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus.
    Li X; Galliher-Beckley A; Huang H; Sun X; Shi J
    Vaccine; 2013 Sep; 31(41):4508-15. PubMed ID: 23933333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of vaccination route (intradermal vs. intramuscular) against porcine reproductive and respiratory syndrome using a modified live vaccine on systemic and mucosal immune response and virus transmission in pigs.
    Renson P; Mahé S; Andraud M; Le Dimna M; Paboeuf F; Rose N; Bourry O
    BMC Vet Res; 2024 Jan; 20(1):5. PubMed ID: 38172908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.
    Galliher-Beckley A; Li X; Bates JT; Madera R; Waters A; Nietfeld J; Henningson J; He D; Feng W; Chen R; Shi J
    Vaccine; 2015 Jul; 33(30):3518-25. PubMed ID: 26049004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of two commercially available porcine reproductive and respiratory syndrome virus (PRRSV) modified-live virus vaccines analyzing the growth performance in 1-day-old vaccinated swine located on endemic farms co-circulating PRRSV-1 and PRRSV-2.
    Yang S; Kang I; Jeong J; Oh T; Park KH; Park SJ; Ham HJ; Jin GR; Lee BH; Chae C
    J Vet Med Sci; 2020 Feb; 82(2):224-228. PubMed ID: 31866631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
    Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
    Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and immune responses after intradermal application of Porcilis PRRS in either the neck or the perianal region.
    Stadler J; Naderer L; Beffort L; Ritzmann M; Emrich D; Hermanns W; Fiebig K; Saalmüller A; Gerner W; Glatthaar-Saalmüller B; Ladinig A
    PLoS One; 2018; 13(9):e0203560. PubMed ID: 30192831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
    Zhang Z; Wang Y; Fan H; Lu C
    Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of different vaccination schedules for sustaining the immune response against porcine reproductive and respiratory syndrome virus.
    Díaz I; Gimeno M; Callén A; Pujols J; López S; Charreyre C; Joisel F; Mateu E
    Vet J; 2013 Aug; 197(2):438-44. PubMed ID: 23499541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation and characteristics of immunological adjuvant activity of purified fraction of Albizia julibrissin saponins.
    Zhu B; He T; Gao X; Shi M; Sun H
    Immunol Invest; 2019 Apr; 48(3):283-302. PubMed ID: 30325683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative evaluation of 4 commercial modified-live porcine reproductive and respiratory syndrome virus (PRRSV) vaccines against heterologous dual Korean PRRSV-1 and PRRSV-2 challenge.
    Oh T; Park SJ; Cho H; Yang S; Ham HJ; Chae C
    Vet Med Sci; 2020 Nov; 6(4):846-853. PubMed ID: 32437071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.